Introduction
============

The causative agent of Legionnaireś pneumonia, *Legionella pneumophila*, replicates intracellularly in free-living amoebae and macrophages of the innate immune system. Within these phagocytic host cells, the bacteria employ a conserved mechanism to form a unique replication-permissive compartment, the "*Legionella*-containing vacuole" (LCV). Thus, amoeba and in particular the genetically tractable social soil amoeba *Dictyostelium discoideum*, are valuable models to study the mechanism of LCV formation on a molecular and cellular level (Solomon and Isberg, [@B56]; Steinert and Heuner, [@B57]; Hilbi et al., [@B22]; Cosson and Soldati, [@B11]). Within macrophages and amoebae, LCVs avoid fusion with lysosomes, but associate with mitochondria and smooth vesicles and eventually fuse with the endoplasmic reticulum (ER; Horwitz, [@B23]; Lu and Clarke, [@B35]; Robinson and Roy, [@B49]). To accommodate the transfer between host cells and environmental niches, *L. pneumophila* switches from a replicative to a transmissive growth phase, which involves a complex gene regulation network, including an apparent quorum sensing system (Molofsky and Swanson, [@B40]; Tiaden et al., [@B59]; Hilbi et al., [@B20]).

Intact LCVs from infected *D. discoideum* amoebae can be isolated and purified using a simple two-step protocol (Urwyler et al., [@B61]). To this end, *D. discoideum* producing the LCV and ER marker calnexin-GFP were infected with *L. pneumophila* fluorescently labeled with DsRed. Subsequently, LCVs in cell-free homogenates were isolated by immuno-magnetic separation using a primary antibody against the *L. pneumophila* "effector protein" SidC (Substrate of Icm/Dot transporter), which specifically decorates the LCV membrane, and a secondary antibody coupled to magnetic beads. The enriched LCVs were further separated by density gradient centrifugation. The proteome of purified LCVs analyzed by liquid chromatography coupled to tandem mass spectrometry (MS/MS) revealed more than 560 host proteins, including small GTPases, as well as protein or lipid kinases and phosphatases (Urwyler et al., [@B62]).

Components of the LCV host cell proteome include several small GTPases of the secretory (Arf1, Rab1, Rab8) or endosomal (Rab7, Rab14) vesicle trafficking pathways (Urwyler et al., [@B62]). Using GFP fusion proteins, the recruitment of the Rab GTPases to the LCV membrane was verified. While Rab8 and Rab14 have not been previously identified on LCVs, the proteome data confirmed earlier findings on LCV localization of Arf1 (Kagan and Roy, [@B29]), Rab1 (Derre and Isberg, [@B13]; Kagan et al., [@B30]), and Rab7 (Clemens et al., [@B9]). The proteome of isolated LCVs was also analyzed in another study that led to the identification of more than 150 host proteins. These include markers of the ER as well as the early and the late endosomal pathways, which are represented by the coatomer or the vacuolar H^+^-ATPase, respectively (Shevchuk et al., [@B54]). In agreement with the notion that *L. pneumophila* modulates phagosome maturation in a sophisticated manner, the effector protein SidK has been shown to inhibit the vacuolar H^+^-ATPase, thereby preventing acidification of the LCV (Xu et al., [@B71]). Together, these studies indicate that LCVs communicate extensively not only with the early and late secretory pathway, but also with early and late steps of the endosomal vesicle trafficking pathway (Figure [1](#F1){ref-type="fig"}).

![***Legionella pneumophila* PI-binding effector proteins and LCV formation**. *L. pneumophila* employs the Icm/Dot T4SS to form a replication-permissive LCV that communicates with secretory as well as with endocytic vesicle trafficking pathways and eventually fuses with the ER. Several effector proteins anchor to the LCV membrane through PtdIns(4)*P* or PtdIns(3)*P* and promote the interaction with the ER and ER-derived vesicles (SidC), catalyze GEF activity of the small GTPase Rab1 (SidM, LidA), or bind PI-metabolizing enzymes such as the 5-phosphatase OCRL1 (LpnE). The Icm/Dot substrate RalF is an Arf1 GEF that might indirectly recruit PI4KIIIβ.](fmicb-02-00091-g001){#F1}

The formation of LCVs is a robust and complex process that requires the bacterial Icm/Dot (Intracellular multiplication/Defective for organelle trafficking) type IV secretion system (T4SS; Segal et al., [@B53]). More than 250 different effector proteins are translocated by the Icm/Dot T4SS into the host cell, where they subvert signal transduction and vesicle trafficking pathways by targeting phosphoinositide (PI) metabolism, small GTPases, ubiquitination, microtubuli-dependent trafficking or apoptotic pathways (Brüggemann et al., [@B5]; Isberg et al., [@B27]; Urwyler et al., [@B60]; Weber et al., [@B68]; Hubber and Roy, [@B24]). While some of the effector proteins target host factors or organelles in a distance from LCVs, many effectors decorate the LCV membrane, thereby directly modulating interactions of this compartment with host vesicles or organelles. In this review, we summarize the current knowledge about how *L. pneumophila* subverts the host cell\'s PI metabolism to form LCVs and replicate intracellularly.

Eukaryotic PI Metabolism and Its Subversion by Intracellular Pathogens
======================================================================

Phosphoinositide glycerolipids play a pivotal role in the regulation of eukaryotic membrane dynamics, cytoskeleton architecture, and signal transduction (De Matteis and Godi, [@B12]; Di Paolo and De Camilli, [@B15]; Michell, [@B39]). The phosphatidylinositol (PtdIns) moiety of these lipids contains glycerol, which is esterified with two fatty acids (usually arachidonic acid and stearic acid) and a *myo*-inositol 1-phosphate head group. The inositol carbohydrate head group of PI lipids is oriented to the cytoplasmic side of membranes and can be hydrolyzed by PI-specific phospholipase C or reversibly phosphorylated/dephosphorylated at the 3, 4, and/or 5 positions by PI kinases or phosphatases, respectively. The resulting mono- or poly-phosphorylated PIs, jointly with activated small GTPases, recruit distinct effector proteins to specific organelles and thereby co-define the identity and integrity of subcellular compartments as well as cellular membrane dynamics (Shin and Nakayama, [@B55]; Behnia and Munro, [@B2]). PtdIns-3-phosphate (PtdIns(3)*P*) or PtdIns-4-phosphate (PtdIns(4)*P*), e.g., represent "signposts" of endosomal and secretory trafficking pathways, respectively, and recruit specific effector proteins to membranes involved in these trafficking routes.

In accordance with the importance of PIs for membrane trafficking of eukaryotes, several intracellular bacteria, such as *Listeria*, *Shigella*, *Salmonella*, *Brucella*, and *Mycobacterium* spp., exploit PI metabolism to infect host cells, establish a replicative niche and subvert host cell signaling (Pizarro-Cerda and Cossart, [@B47]; Hilbi, [@B19]; Weber et al., [@B68]). The subversion of PI metabolism by vacuolar pathogens has been studied in some detail in *Mycobacterium tuberculosis*, the causative agent of the chronic pulmonary disease tuberculosis. The pathogen grows in "*Mycobacterium*-containing vacuoles" (MCVs), which accumulate the small GTPase Rab5 but not Rab7 and exclude the acidifying vacuolar H^+^-ATPase as well as lysosomal hydrolases (Russell et al., [@B50]).

*Mycobacterium tuberculosis* adopts a dual strategy involving lipid toxins and PI-metabolizing enzymes to keep the levels of PtdIns(3)*P* on MCVs low, thus arresting the bactericidal endocytic pathway. The glycosylated PI analogue lipoarabinomannan (LAM) and its precursor PtdIns mannoside (PIM) are trafficking toxins (Chua et al., [@B8]). LAM inhibits a calmodulin kinase II-dependent activation of the class III PtdIns 3-kinase (PI3K) hVps34 (Vergne et al., [@B64]) and thereby reduces PtdIns(3)*P* on MCVs and prevents the delivery of the vacuolar H^+^-ATPase as well as acidic hydrolases (Fratti et al., [@B17]). Conversely, PIM promotes the homotypic fusion of phagosomes with early endosomes in a PI3K-independent manner, thus allowing continuous communication between MCVs and endosomes, despite the trafficking block imposed by the depletion of PtdIns(3)*P* (Chua et al., [@B8]; Vergne et al., [@B66]). To further reduce PtdIns(3)*P* on MCVs, *M. tuberculosis* secretes the PI phosphatases SapM (Vergne et al., [@B65]) and MptpB (Beresford et al., [@B3]).

The role of bacterial PI-binding effector proteins, LCV PIs and host PI-modulating enzymes for LCV formation and intracellular replication of *L. pneumophila* will be discussed in the following sections.

The Icm/Dot Substrate SidC Binds PtdIns(4)*P* and Promotes LCV-ER Fusion
========================================================================

The *L. pneumophila* protein SidC was identified as an Icm/Dot substrate by a Cre/*loxP*-based protein translocation assay, using Icm/Dot-mediated conjugative transport between a donor and a recipient bacterium (Luo and Isberg, [@B36]). Immuno-fluorescence studies further showed that SidC is translocated to the cytoplasmic side of the vacuole, where the protein decorates the LCV membrane.

The amount of SidC bound to the LCV membrane depends on the presence or absence of PI3Ks in *D. discoideum* (Weber et al., [@B70]), and therefore, we tested *in vitro*, whether purified GST-SidC fusion protein directly binds PIs. Indeed, purified SidC and its paralogue SdcA (72% identity) were found to selectively bind PtdIns(4)*P* in protein--lipid overlay assays (Figure [2](#F2){ref-type="fig"}), as well as in phospholipid vesicle pull down experiments (Weber et al., [@B70]). In contrast, the Icm/Dot substrate SidD did not bind to any PIs or other lipids. Further analysis of the PtdIns(4)*P*-binding domain of SidC revealed that a 20-kDa fragment near the C-terminus was sufficient to selectively bind the PI (Ragaz et al., [@B48]; Figure [2](#F2){ref-type="fig"}). The PtdIns(4)*P*-binding domain was termed "P4C" (PtdIns(4)*P*-binding domain of SidC) and shows no homology with eukaryotic PI recognition folds, such as the PH (pleckstrin homology), PX (phagocyte oxidase homology), FYVE (Fab1-YotB-Vac1-EEA1), ENTH/ANTH (epsin/AP180 N-terminal homology), FERM (band 4.1-ezrin-radixin-moesin) or KR (lysine/arginine) domains (Downes et al., [@B16]; Varnai and Balla, [@B63]; Lemmon, [@B32]).

![**Protein-lipid overlay of *L. pneumophila* PI-binding effector proteins**. GST fusion proteins (200 nM) of SidC, SidC~P4C~, SidM, LidA, LpnE, and RalF were affinity purified, and binding to different synthetic di-hexadecanoyl-PI lipids (100 pmol) immobilized on nitrocellulose membranes was analyzed by a protein--lipid overlay assay using an anti GST antibody. Left lanes: lysophosphatidic acid (LPA), lysophosphocholine (LPC), phosphatidylinositol (PtdIns), PtdIns phosphate (PI(n)*P*), phosphatidylethanolamine (PE), phosphatidylcholine (PC). Right lanes: sphingosine-1-phosphate (S1*P*), PtdIns phosphate (PI(n)*P*), phosphatidic acid (PA), phosphatidylserine (PS).](fmicb-02-00091-g002){#F2}

Deletion of *sidC* and the adjacent gene *sdcA* from the *L. pneumophila* genome does not impair intracellular replication of the bacteria (Luo and Isberg, [@B36]; Ragaz et al., [@B48]). Furthermore, in absence of *sidC* and *sdcA* the acquisition of Rab1 or the endosomal marker p80 is not altered; yet, only 20% of LCVs acquire the ER markers calnexin-GFP and GFP-HDEL, indicating that the interaction of LCVs with the ER is severely impaired upon deletion of these genes (Ragaz et al., [@B48]). The finding that reduced ER acquisition does not impair intracellular replication of the Δ*sidC*-*sdcA* strain was unexpected, since defective ER acquisition of LCVs due to a dominant negative form of the small GTPase Sar1 (Kagan and Roy, [@B29]) or due to the lack of the Icm/Dot substrate SidJ (Liu and Luo, [@B34]) did inhibit intracellular growth of *L. pneumophila*.

The ER acquisition phenotype of *L. pneumophila* lacking *sidC* and *sdcA* is complemented by either *sidC* or *sdcA*, and the amount of calnexin-GFP and SidC on LCVs is directly proportional. Biochemical experiments revealed that SidC and a 70-kDa N-terminal fragment incubated with lysates of macrophages or *D. discoideum* bind ER and secretory vesicles (containing calnexin, protein disulfide isomerase and Rab1), but neither lysosomes (containing LAMP-1or "common antigen-1") nor Golgi fragments (containing giantin). Thus, the N-terminal part of SidC promotes the communication of LCVs with ER-derived vesicles, while the C-terminal part harbors the Icm/Dot translocation determinant and the PtdIns(4)*P*-binding domain P4C (Figure [1](#F1){ref-type="fig"}).

SidC and in particular the 20-kDa PtdIns(4)*P*-binding fragment P4C are stable and can be produced with high yields in *E. coli* as GST fusion proteins (Weber et al., [@B70]; Ragaz et al., [@B48]). Moreover, P4C can be ectopically produced in *D. discoideum*, and the probe labels the PtdIns(4)*P*-positive LCV membrane in amoebae infected with *L. pneumophila*. Similarly, P4C might be a suitable PtdIns(4)*P* probe in other eukaryotic cells, including yeast, *Drosophila melanogaster* and mammalian cells. Taken together, the purified or heterologously produced SidC and P4C proteins are useful as prokaryotic PtdIns(4)*P*-binding probes in biochemical and cell biological experiments.

The Rab1 GEF SidM is a Major PtdIns(4)*P*-Binding Effector Protein
==================================================================

To address the question, whether *L. pneumophila* proteins other than SidC also bind to PIs, bacterial lysates were incubated with agarose beads coated either with one of the seven naturally occurring mono- or poly-phosphorylated PIs or with PtdIns. The eluate from washed beads was separated by SDS-PAGE, and a single protein binding predominantly and specifically to PtdIns(4)*P* was identified by MS as the effector protein SidM (also termed DrrA; Brombacher et al., [@B4]). Further analysis showed that SidM is indeed a major *L. pneumophila* PtdIns(4)*P*-binding protein (Figure [2](#F2){ref-type="fig"}), which competes with SidC for binding to this PI on LCVs. The PtdIns(4)*P*-binding domain of SidM comprises a 12-kDa fragment that was termed "P4M" (PtdIns(4)*P*-binding of SidM) and is not related to other prokaryotic or eukaryotic PI-binding domains. The high-resolution structure of a SidM fragment including the P4M domain revealed that the effector protein employs a novel fold to bind PtdIns(4)*P* with an unprecedented high affinity in the nanomolar range (Schoebel et al., [@B51]). Compared to full length SidM, the affinity of the 12-kDa P4M domain for PtdIns(4)*P* is reduced (Brombacher et al., [@B4]), and therefore, the 20-kDa P4C domain, which retains its PI-binding affinity, appears to be the superior PtdIns(4)*P* probe.

SidM is an Icm/Dot substrate and shows activity as a Rab1 guanine nucleotide exchange factor (GEF), thus activating and recruiting this small GTPase to LCVs (Machner and Isberg, [@B37]; Murata et al., [@B42]). The finding that the GEF SidM binds to PtdIns(4)*P* represents a novel link between the modulation of host GTPases and the exploitation of PIs by pathogenic bacteria (Figure [1](#F1){ref-type="fig"}). SidM has been suggested to also have activity as a Rab GDP dissociation inhibitor (GDI) displacement factor (GDF), which removes GDI from Rab1-GDP, thus allowing access of the GEF domain to the small GTPase (Ingmundson et al., [@B26]; Machner and Isberg, [@B38]). However, the GDF activity turned out to be intrinsic to the GEF activity, rather than a distinct activity (Schoebel et al., [@B52]).

The membrane cycle of Rab1 is closed by the Icm/Dot substrate LepB, which is a Rab1 GTPase activating protein (GAP) that inactivates and removes Rab1 from membranes (Ingmundson et al., [@B26]). LepB and another *L. pneumophila* protein with weak homology to SNAREs and tethering proteins termed LepA have originally been proposed to promote the non-lytic egress of the bacteria from amoebae via a novel pathway, leading to bacteria-filled respirable vesicles (Chen et al., [@B6], [@B7]).

Interestingly, SidM also catalyzes the "AMPylation" (adenosine mono-phosphorylation) of Rab1 at an N-terminal tyrosine residue (Müller et al., [@B41]). AMPylation of Rab1 "constitutively activates" the small GTPase, since the covalent modification barely affects the GEF activity of SidM but impairs the GAP activity of LepB. In addition to Rab1, SidM AMPylates several other Rab GTPases, including Rab8 and Rab14 (Müller et al., [@B41]), which are also recruited to LCVs (Urwyler et al., [@B62]). Thus, SidM might prolong the activation of several Rab GTPases on the LCV membrane. Rab1-AMP does not bind eukaryotic Rab1 effectors anymore, but still interacts with a SidM auxiliary protein: the *L. pneumophila* Rab1 effector LidA (Müller et al., [@B41]).

LidA (Lowered viability in the presence of *dotA*) is an Icm/Dot substrate that decorates LCVs and promotes the recruitment of early secretory vesicles to LCVs (Conover et al., [@B10]; Derre and Isberg, [@B14]). In biochemical experiments LidA was found to interact with several small Rab GTPases (Rab1, Rab6, Rab8) and to support the GEF activity of SidM by binding to GDI-free Rab1 (Machner and Isberg, [@B37]). In turn, wild-type and constitutively active Rab8 also interact with LidA in *L. pneumophila* lysates (Urwyler et al., [@B60]). LidA represents another effector that localizes to the LCV membrane by interacting with distinct PIs, since it binds to PtdIns(4)*P* and, with an apparently slightly lower affinity, also to PtdIns(3)*P* (Brombacher et al., [@B4]; Figure [2](#F2){ref-type="fig"}).

Lastly, the Icm/Dot-translocated effector protein RalF does not bind to any PIs or other lipids (Brombacher et al., [@B4]; Figure [2](#F2){ref-type="fig"}). RalF (Recruitment of Arf1 to the *Legionella* phagosome) was the first Icm/Dot substrate identified and characterized as an Arf1-specific GEF, which is required to recruit Arf1 to the LCV membrane (Nagai et al., [@B43]; Figure [1](#F1){ref-type="fig"}). Upon deletion of *ralF* from the *L. pneumophila* chromosome the small GTPase Arf1 does not localize to LCVs anymore, yet intracellular replication of the bacteria is not impaired. Taken together, these results indicate that two classes of Icm/Dot-translocated *L. pneumophila* GEFs localize to LCV membranes, one of which by binding to PIs.

The Virulence Factor LpnE Binds PtdIns(3)*P* and OCRL1
======================================================

LpnE (*Legionella pneumophila* entry) is a Sel1 repeat protein of the tetratricopeptide-repeat family (Newton et al., [@B44]). The *lpnE* gene was found to be specific for *L. pneumophila* in a subtractive genomic hybridization screen by comparing *L. pneumophila* to non-virulent *L. micdadei*. In agreement with a function for LpnE as a virulence factor, an *L. pneumophila lpnE* deletion mutant strain is impaired for infection of *Acanthamoeba castellanii* amoebae, entry into human macrophage-like cells, intracellular trafficking, and virulence in the A/J mouse strain (Newton et al., [@B45]). While LpnE is secreted into *L. pneumophila* culture supernatants, the mechanism remains unclear, since neither the Icm/Dot T4SS nor the Lsp T2SS seems to be involved.

Purified recombinant LpnE selectively binds PtdIns(3)*P* (Weber et al., [@B67]; Figure [2](#F2){ref-type="fig"}), indicating that the Sel1 repeat protein represents another PI-binding virulence factor of *L. pneumophila*. Moreover, LpnE interacts with the N-terminus of the human enzyme OCRL1 (OCRL1~1--236~) heterologously produced in *D. discoideum*, and conversely, purified GST-OCRL1~1--236~ binds LpnE in *L. pneumophila* lysates. OCRL1 (Oculocerebrorenal syndrome of Lowe 1) and its *Dictyostelium* homologue Dd5P4 (*D. discoideum* 5-phosphatase 4) are PI-metabolizing enzymes implicated in intracellular replication of *L. pneumophila* (see below).

In summary, the studies discussed above indicate that *L. pneumophila* exploits the mono-phosphorylated host PIs PtdIns(4)*P* and PtdIns(3)*P* to anchor the effector proteins SidC, SidM, LidA, and LpnE to the LCV membrane. The PI-binding effectors then interfere with host vesicle trafficking and signal transduction (Figure [1](#F1){ref-type="fig"}).

Host PIs and PI-Metabolizing Enzymes Involved in LCV Formation
==============================================================

Since the Icm/Dot substrates SidC, SidM, and LidA are present on the LCV membrane and bind to PtdIns(4)*P in vitro*, this PI is expected to be a lipid component of LCVs and enriched on this compartment. Indeed, PtdIns(4)*P* was identified on LCV membranes by using either an anti-PtdIns(4)*P* antibody, or purified GST fusion proteins of the eukaryotic PH~FAPP1~ domain (specifically binding PtdIns(4)*P*) or prokaryotic SidC as a probe (Weber et al., [@B70]).

The mammalian enzyme OCRL1 and *D. discoideum* Dd5P4 are homologous inositol-polyphosphate 5-phosphatases, which hydrolyze PtdIns(4,5)*P*~2~ to yield PtdIns(4)*P*. GFP fusion proteins of OCRL1 or Dd5P4 localize to LCVs via their N-termini (OCRL1~1--236~, Dd5P4~1--132~) in *D. discoideum*, and OCRL1 accumulates on LCVs in RAW 264.7 macrophages (Weber et al., [@B67]; Figure [1](#F1){ref-type="fig"}). In *D. discoideum* lacking Dd5P4 the amount of SidC on LCVs is reduced, suggesting that in absence of Dd5P4 less PtdIns(4)*P* is produced on the LCV membrane, and consequently, less SidC binds to this compartment. Interestingly, two to three orders of magnitude more *L. pneumophila* are released from *D. discoideum* lacking Dd5P4, and therefore, the bacteria grow intracellularly much more efficiently in absence of this inositol-polyphosphate 5-phosphatase. It is currently unknown, how Dd5P4 restricts intracellular growth of *L. pneumophila*. However, since the mammalian homologue OCRL1 promotes retrograde trafficking from endosomes to the *trans*-Golgi network (TGN; Johannes and Popoff, [@B28]), a functional retrograde vesicle trafficking pathway might play a role.

A host PI-metabolizing enzyme termed PtdIns 4-kinase IIIβ (PI4KIIIβ) is likely also involved in the production of PtdIns(4)*P* on LCVs. Depletion of PI4KIIIβ by RNA interference in *Drosophila melanogaster* Kc167 phagocytes, which are permissive for intracellular growth of *L. pneumophila*, significantly reduced the amount of SidC on LCV membranes (Brombacher et al., [@B4]). The effect was specific for PI4KIIIβ, since depletion of the isoenzymes PI4KIIIα or PI4KIIα did not reduce the amount of LCV-bound SidC. PI4KIIIβ forms PtdIns(4)*P* in the TGN upon recruitment by the activated small GTPase Arf1 (Godi et al., [@B18]). Yet, it is currently unknown, whether PI4KIIIβ also localizes to LCVs. Together, these findings suggest that OCRL1/Dd5P4 as well as PI4KIIIβ are implicated in LCV formation and likely catalyze the production of PtdIns(4)*P* on the LCV membrane (Figure [1](#F1){ref-type="fig"}).

PI3Ks represent another class of PI-metabolizing enzymes that play important roles for vesicle trafficking and signal transduction in eukaryotic cells. *D. discoideum* deletion mutants and pharmacological inhibitors revealed that the uptake of *icm*/*dot* mutant *L. pneumophila* depends on PI3Ks. In contrast, the efficient uptake of wild-type *L. pneumophila* by *D. discoideum* (Hilbi et al., [@B21]; Weber et al., [@B69],[@B70]) or by human macrophage-like HL-60 cells (Khelef et al., [@B31]) is barely affected by PI3Ks, indicating that Icm/Dot-proficient bacteria might bypass PI3Ks during entry. In another study, the uptake of *L. pneumophila* was reported to require PI3Ks (Tachado et al., [@B58]). Yet, this work used murine J774A.1 macrophage-like cells, which do not support intracellular growth of *L. pneumophila*. Thus, the formation of a replication-permissive vacuole by *L. pneumophila* might depend on bypassing PI3K signaling.

Upon deletion or inhibition of PI3Ks in *D. discoideum*, *L. pneumophila* replicates more efficiently within the amoebae, and *icm*/*dot* mutant bacteria are killed less effectively, in agreement with the well-established role for PI3Ks in the bactericidal endocytic pathway (Weber et al., [@B70]). Recent studies confirmed that *L. pneumophila* interferes with the PI-sensitive fusion of LCVs with acidic vacuoles and indicated that the inhibition of intracellular replication by PI3Ks is restricted to early steps in the infection (Peracino et al., [@B46]). Notably, the stimulation of intracellular replication of *L. pneumophila* by pharmacological "PI3K inhibitors" might also be due to an effect on PI4KIIIβ (see above). PI4KIIIβ is a type III PI4K that, in contrast to the type II PI4Ks, is also inhibited by wortmannin (Balla and Balla, [@B1]).

Finally, the 30-kDa inositol monophosphate phosphatase IMPA was identified as a host component of purified intact LCVs, suggesting that this PI phosphatase might also play a role in LCV formation and intracellular replication of *L. pneumophila* (Urwyler et al., [@B62]). In summary, the PI lipid PtdIns(4)*P* as well as the host PI-metabolizing enzymes OCRL1/Dd5P4, PI4KIIIβ, PI3Ks, and IMPA are likely constituents of LCVs and implicated in its formation.

Modulation of the PI Pattern on LCVs by *L. Pneumophila*
========================================================

PtdIns(4)*P* accumulates on LCVs harboring wild-type but not *icm*/*dot* mutant *L. pneumophila* (Weber et al., [@B70]). Since these vacuoles are vastly different from one another, comparing the two compartments does not indicate, whether the PI pattern on LCVs is modulated directly by the Icm/Dot T4SS. However, upon infection of phagocytes approximately 20% of wild-type *L. pneumophila* do not reside in a calnexin-positive ER-derived compartment, but rather in a lysosomal compartment, which is positive for the vacuolar H^+^-ATPase component VatM in *D. discoideum* and for LAMP-1 in macrophages. The quantification of PtdIns(4)*P* on VatM-positive vacuoles containing either wild-type or *icm*/*dot* mutant *L. pneumophila* revealed that 42% of the former, but only 6% of the latter accumulated PtdIns(4)P (Weber et al., [@B70]). This finding indicates that wild-type *L. pneumophila* survive in a VatM-positive compartment and interfere with the LCV PI metabolism in an Icm/Dot-dependent manner. Furthermore, modulation of the LCV PI pattern (increasing the amount of PtdIns(4)*P*) is not sufficient to generate a replication-permissive ER-derived compartment.

To modulate the LCV PI pattern *L. pneumophila* effectors might (i) activate small GTPases and thus recruit host PI-metabolizing enzymes, (ii) titrate (mask) PIs, (iii) produce factors directly activating or inhibiting host PI-metabolizing enzymes, and/or (iv) translocate bacterial PI-metabolizing enzymes, i.e., PI phosphatases or kinases (Figure [3](#F3){ref-type="fig"}). Currently, no *L. pneumophila* factors are known, which directly modify the activity of host PI-metabolizing enzymes or phosphorylate/dephosphorylate PIs.

![**Modulation of the LCV PI pattern by *L. pneumophila* effectors**. *L. pneumophila* modulates the LCV host PI pattern through the Icm/Dot T4SS. Translocated factors might (I) activate small GTPases and thus recruit host PI-metabolizing enzymes, (II) titrate (mask) PIs, (III) directly activate or inhibit host PI-metabolizing enzymes, and/or (IV) represent bacterial PI phosphatases or kinases.](fmicb-02-00091-g003){#F3}

*Legionella pneumophila* produces and translocates two GEFs that recruit and activate small GTPases and thus might indirectly modulate the LCV PI pattern: RalF (Nagai et al., [@B43]) and SidM (Machner and Isberg, [@B37]; Murata et al., [@B42]) recruit the small GTPases Arf1 and Rab1to LCVs (Figure [1](#F1){ref-type="fig"}). Arf1 has been shown to recruit PI4KIIIβ at the TGN (Godi et al., [@B18]), and a number of small GTPases including Arf1 (Lichter-Konecki et al., [@B33]) and Rab1 (Hyvola et al., [@B25]) target OCRL1 to endosomal membranes. Both PI4KIIIβ and OCRL1 produce PtdIns(4)*P* and are likely enzymatically active on LCVs (Brombacher et al., [@B4]; Weber et al., [@B67]). If *L. pneumophila* modulates the PI levels on LCVs via the translocation of GEFs, the concentration of PtdIns(4)*P* on LCVs should decrease in absence of RalF or SidM, and consequently, less SidC should bind to LCVs. However, in absence of RalF the amount of SidC on LCVs remained constant, and in absence of SidM even significantly more SidC bound to LCVs, accounting also for the fact that SidM itself binds to PtdIns(4)*P* (Brombacher et al., [@B4]). In light of these results, *L. pneumophila* likely does not (or at least not exclusively) modulate the LCV PI pattern by the indirect recruitment of host PI-metabolizing enzymes. Thus, while it is clear that *L. pneumophila* modulates the LCV PI pattern in an Icm/Dot-dependent manner, the mechanistic aspects of this process have not been elucidated yet.

Conclusions and Perspectives
============================

*Legionella pneumophila* employs the Icm/Dot T4SS to form in a complex and robust process a replication-permissive LCV. Several Icm/Dot-translocated effector proteins anchor to the LCV membrane through PtdIns(4)*P* or PtdIns(3)*P* and promote the interaction of LCVs with host vesicles and organelles, small GTPases or PI-metabolizing enzymes. The PI-binding domains of these effectors bind PIs with high affinity and are useful as specific lipid probes. Further research should address the identification and characterization of other *L. pneumophila* PI-binding effector proteins. Of particular interest is the mechanism, by which *L. pneumophila* actively modulates the LCV PI pattern in an Icm/Dot-dependent manner. A comprehensive understanding of how *L. pneumophila* exploits the PI metabolism of host cells will continue to provide mechanistic insights into basic biological processes and shed light on the virulence of this important opportunistic human pathogen.
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